Alfuzosin hydrochlo
Ended Awarded Last action
- Contract number
- SPE2DP25F6878
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $1,948
Award facts
- Contract value 100% obligated
- $1,948.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Change Order | -$3,896 | |
| Original award | $5,845 |
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a firm fixed-price delivery order valued at $1,948.20 for Alfuzosin Hydrochloride, with an ultimate completion date of September 22, 2025. This delivery order was issued without a set-aside designation and represents a single purchase under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency (DLA) under the SPE2DB program, which is valued at approximately $500 million and remains valid through November 2026. The place of performance is located in Park Ridge, Illinois, and the award is funded by the Medical Supply Chain, a defense-focused federal agency.
The DLA's SPE2DB program enables the issuance of firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting military health facilities worldwide. Alfuzosin Hydrochloride, a prescription medication used to treat benign prostatic hyperplasia, falls within the broad portfolio of branded and generic drugs, biologics, and medical consumables that DMS Pharmaceutical Group is authorized to supply. As a critical supplier in the federal pharmaceutical supply chain with a robust history of federal contract awards since 2001, DMS Pharmaceutical Group continues to provide essential pharmacy products and distribution services directly to Department of Defense healthcare sites across the nation.
Quick answers
Who was awarded contract SPE2DP25F6878?
SPE2DP25F6878 was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on May 13, 2025.
How much is contract SPE2DP25F6878 worth?
The government has obligated $1,948 on SPE2DP25F6878.
Is contract SPE2DP25F6878 an order under another contract?
Yes. SPE2DP25F6878 is a delivery order under SPE2DX15D9383, an indefinite delivery contract.
Was contract SPE2DP25F6878 competed?
The extent of competition for SPE2DP25F6878 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award